139 related articles for article (PubMed ID: 6150981)
1. Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17 alpha,21-dipropionate in human liver and lung homogenate.
Andersson P; Ryrfeldt A
J Pharm Pharmacol; 1984 Nov; 36(11):763-5. PubMed ID: 6150981
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments.
Chanoine F; Grenot C; Heidmann P; Junien JL
Drug Metab Dispos; 1991; 19(2):546-53. PubMed ID: 1676668
[TBL] [Abstract][Full Text] [Related]
3. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man.
Johansson SA; Andersson KE; Brattsand R; Gruvstad E; Hedner P
Eur J Clin Pharmacol; 1982; 22(6):523-9. PubMed ID: 7128664
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices.
Nave R; Fisher R; McCracken N
Respir Res; 2007 Sep; 8(1):65. PubMed ID: 17883839
[TBL] [Abstract][Full Text] [Related]
5. Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate.
Würthwein G; Rohdewald P
Biopharm Drug Dispos; 1990 Jul; 11(5):381-94. PubMed ID: 2207292
[TBL] [Abstract][Full Text] [Related]
6. Comparative kinetics of metabolism of beclomethasone propionate esters in human lung homogenates and plasma.
Foe K; Brown KF; Seale JP
J Pharm Sci; 2000 Sep; 89(9):1143-50. PubMed ID: 10944379
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid.
Ryrfeldt A; Andersson P; Edsbäcker S; Tönnesson M; Davies D; Pauwels R
Eur J Respir Dis Suppl; 1982; 122():86-95. PubMed ID: 6958498
[TBL] [Abstract][Full Text] [Related]
8. Metabolism kinetics of beclomethasone propionate esters in human lung homogenates.
Foe K; Cutler DJ; Brown KF; Seale JP
Pharm Res; 2000 Aug; 17(8):1007-12. PubMed ID: 11028949
[TBL] [Abstract][Full Text] [Related]
9. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man.
Johansson SA; Andersson KE; Brattsand R; Gruvstad E; Hedner P
Eur J Respir Dis Suppl; 1982; 122():74-82. PubMed ID: 6958496
[TBL] [Abstract][Full Text] [Related]
10. Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide.
Boobis AR
Respir Med; 1998 Jul; 92 Suppl B():2-6. PubMed ID: 10193529
[TBL] [Abstract][Full Text] [Related]
11. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
Thalén A; Brattsand R; Andersson PH
Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062
[TBL] [Abstract][Full Text] [Related]
12. Metabolic pathways of the topical glucocorticoid budesonide in man.
Edsbäcker S; Jönsson S; Lindberg C; Ryrfeldt A; Thalén A
Drug Metab Dispos; 1983; 11(6):590-6. PubMed ID: 6140145
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation rate (in vitro) and systemic potency (in vivo) of the topical glucocorticoid budesonide in male and female rats.
Andersson P; Brattsand R; Edsbäcker S; Källström L; Ryrfeldt A
J Steroid Biochem; 1982 Dec; 17(6):703-6. PubMed ID: 7176660
[TBL] [Abstract][Full Text] [Related]
14. Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects.
Brown PH; Matusiewicz SP; Shearing C; Tibi L; Greening AP; Crompton GK
Thorax; 1993 Oct; 48(10):967-73. PubMed ID: 8256242
[TBL] [Abstract][Full Text] [Related]
15. Metabolic acetal splitting of budesonide. A novel inactivation pathway for topical glucocorticoids.
Edsbäcker S; Andersson P; Lindberg C; Ryrfeldt A; Thalén A
Drug Metab Dispos; 1987; 15(3):412-7. PubMed ID: 2886320
[TBL] [Abstract][Full Text] [Related]
16. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.
Birkebaek NH; Esberg G; Andersen K; Wolthers O; Hassager C
Arch Dis Child; 1995 Dec; 73(6):524-7. PubMed ID: 8546510
[TBL] [Abstract][Full Text] [Related]
17. Liver metabolism of budesonide in rat, mouse, and man. Comparative aspects.
Edsbäcker S; Andersson P; Lindberg C; Paulson J; Ryrfeldt A; Thalén A
Drug Metab Dispos; 1987; 15(3):403-11. PubMed ID: 2886319
[TBL] [Abstract][Full Text] [Related]
18. Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma.
Kiviranta K; Turpeinen M
Thorax; 1993 Oct; 48(10):974-8. PubMed ID: 8256243
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymes.
Roberts JK; Moore CD; Ward RM; Yost GS; Reilly CA
J Pharmacol Exp Ther; 2013 May; 345(2):308-16. PubMed ID: 23512537
[TBL] [Abstract][Full Text] [Related]
20. Development of new glucocorticosteroids with a very high ratio between topical and systemic activities.
Brattsand R; Thalén A; Roempke K; Källström L; Gruvstad E
Eur J Respir Dis Suppl; 1982; 122():62-73. PubMed ID: 6958495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
